Top pharma CEO compensation in 2018

Top CEO compensations provided by pharmaceutical companies in 2018

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2019

Region

Worldwide

Survey time period

2018

Number of respondents

base: 200 life sciences companies

Supplementary notes

For the report, BioPharma Dive explicitly grouped firms in these 3 categories: Large cap biotech: Market capitalization greater than $10 billion. Mid-sized biotech: Market capitalization between $2 billion and $10 billion. Small biotech: Market capitalization between $500 million and $2 billion.

This statistic is for firms in all the categories.

CEO compensation includes base salary, cash bonuses and long-term stock and option awards, as described in annual proxy filings.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical industry in Spain "

Other statistics that may interest you Pharmaceutical industry in Spain

Overview

6

International trade

6

Pharmaceutical sales

6

Pharmaceutical expenditure of the National Health System

6

Research and development

6

Company rankings

6

Further related statistics

10
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.